載入...
Stroke onset to needle delay: Where these golden hours are lost? An Egyptian center experience
BACKGROUND: The use of intravenous recombinant tissue plasminogen activator (IV r-tPA) in early acute ischemic stroke (AIS) management faces a lot of difficulties in developing countries due to lessened guideline development with consecutive pre- and intra-hospital delay. OBJECTIVES: The objective w...
Na minha lista:
| 發表在: | eNeurologicalSci |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6330381/ https://ncbi.nlm.nih.gov/pubmed/30671551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ensci.2019.01.003 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|